Camidanlumab
Modify Date: 2024-04-08 22:50:19
Camidanlumab structure
|
Common Name | Camidanlumab | ||
|---|---|---|---|---|
| CAS Number | 921618-45-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CamidanlumabCamidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including lymphoma and leukemia[1]. |
| Name | Camidanlumab |
|---|
| Description | Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including lymphoma and leukemia[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |